{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T20:42:17Z","timestamp":1694464937332},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2]]},"abstract":"<jats:p>Rats repeatedly exposed to the bar test following injections with a dopamine D2-like receptor antagonist such as haloperidol show increased descent latencies, suggesting that contextual stimuli may lose their ability to elicit approach and other responses. Here, we showed that rats took progressively longer to initiate descent from a horizontal bar across sessions following daily intraperitoneal treatment (paired group) with the D2-like receptor antagonist, spiroperidol (0.125 and 0.25\u2009mg\/kg), but not in the control group that received 0.25\u2009mg\/kg in their home cage and testing following saline. When both groups were tested following an injection of spiroperidol or following saline, a sensitized and a conditioned increase in descent latency, respectively, were observed in the paired but not in the unpaired group. No evidence of sensitization or conditioning was found with the substituted benzamide compound, eticlopride (0.15\u20130.5\u2009mg\/kg), or the D2-like receptor partial agonist, aripiprazole (0.25\u20130.5\u2009mg\/kg). The different effects of these agents on learning may be related to different region-specific affinities for dopamine receptors or differences in receptor dissociation profiles. We suggest that the behavioural changes observed in spiroperidol-treated rats may reflect inverse incentive learning.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000264","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T09:00:57Z","timestamp":1475226057000},"page":"30-36","source":"Crossref","is-referenced-by-count":1,"title":["Spiroperidol, but not eticlopride or aripiprazole, produces gradual increases in descent latencies in the bar test in rats"],"prefix":"10.1097","volume":"28","author":[{"given":"Jeffery F.","family":"Rocca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua G.","family":"Lister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Beninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230910","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00008877-200311000-00009","article-title":"Context-dependent catalepsy intensification is due to classical conditioning and sensitization","volume":"14","author":"Amtage","year":"2003","journal-title":"Behav Pharmacol"},{"key":"R2-20230910","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0006-8993(86)91547-7","article-title":"Behavioral effects of a single neuroleptic treatment grow with the passage of time","volume":"385","author":"Antelman","year":"1986","journal-title":"Brain Res"},{"key":"R3-20230910","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1017\/S1461145711001696","article-title":"Haloperidol conditioned catalepsy in rats: a possible role for D1-like receptors","volume":"15","author":"Banasikowski","year":"2012a","journal-title":"Int J Neuropsychopharmacol"},{"key":"R4-20230910","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.euroneuro.2012.02.004","article-title":"Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904","volume":"22","author":"Banasikowski","year":"2012b","journal-title":"Eur Neuropsychopharmacol"},{"key":"R5-20230910","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0091-3057(90)90094-X","article-title":"Sensitization versus tolerance to haloperidol-induced catalepsy: multiple determinants","volume":"36","author":"Barnes","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"key":"R8-20230910","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0893-133X(99)00061-5","article-title":"Conditioning to injection procedures and repeated testing increase SCH 23390-induced catalepsy in mice","volume":"21","author":"Chinen","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"R9-20230910","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/1043-6618(95)80030-1","article-title":"Behavioural assessment in rats of the antipsychotic potential of the potent dopamine D2 receptor antagonist, (\u2212)eticlopride","volume":"31","author":"Ferrari","year":"1995","journal-title":"Pharmacol Res"},{"key":"R12-20230910","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0091-3057(92)90102-L","article-title":"Comparative studies of sulpiride and classical neuroleptics on induction of catalepsy, locomotor activity, and brain dopamine metabolism in mice","volume":"41","author":"Fujiwara","year":"1992","journal-title":"Pharmacol Biochem Behav"},{"key":"R14-20230910","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0091-3057(87)90490-4","article-title":"Repeated testing of rats markedly enhances the duration of effects induced by haloperidol on treadmill locomotion, catalepsy, and a conditioned avoidance response","volume":"27","author":"Hillegaart","year":"1987","journal-title":"Pharmacol Biochem Behav"},{"key":"R38-20230910","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0014-2999(97)00140-4","article-title":"Duration of catalepsy correlates with increased intrastriatal sulpiride","volume":"326","author":"Horikawa","year":"1997","journal-title":"Euro J pharmacol"},{"key":"R15-20230910","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0024-3205(78)90032-2","article-title":"A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugs","volume":"23","author":"Jenner","year":"1978","journal-title":"Life Sci"},{"key":"R16-20230910","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1007\/s11095-014-1358-7","article-title":"Dopamine D2 receptor occupancy as a predictor of catalepsy in rats: a pharmacokinetic-pharmacodynamic modeling approach","volume":"31","author":"Johnson","year":"2014","journal-title":"Pharm Res"},{"key":"R17-20230910","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1080\/00207450902984002","article-title":"Rotarod impairment: catalepsy-like screening test for antipsychotic side effects","volume":"119","author":"Kirschbaum","year":"2009","journal-title":"Int J Neurosci"},{"key":"R18-20230910","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00008877-200302000-00005","article-title":"Catalepsy intensifies context-dependently irrespective of whether it is induced by intermittent or chronic dopamine deficiency","volume":"14","author":"Klein","year":"2003","journal-title":"Behav Pharmacol"},{"key":"R19-20230910","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00210-010-0577-7","article-title":"Pharmacological blockade of dopamine D2 receptors by aripiprazole is not associated with striatal sensitization","volume":"383","author":"Koener","year":"2011","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R20-20230910","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-0447.1984.tb06864.x","article-title":"Studies on the mechanism of action of substituted benzamide drugs","volume":"311","author":"K\u00f6hler","year":"1984","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"R21-20230910","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0920-9964(98)00105-4","article-title":"Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials","volume":"35","author":"Leucht","year":"1999","journal-title":"Schizophr Res"},{"key":"R22-20230910","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0014-2999(02)01602-3","article-title":"Effect of the amisulpride isomers on rat catalepsy","volume":"444","author":"Marchese","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"R23-20230910","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.pnpbp.2003.09.006","article-title":"Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality","volume":"27","author":"M\u00f6ller","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R24-20230910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00023210-200519001-00001","article-title":"Second-generation (atypical) antipsychotics and metabolic effects","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"key":"R25-20230910","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.neuropharm.2007.10.010","article-title":"Effects of aripiprazole\/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats","volume":"54","author":"Nordquist","year":"2008","journal-title":"Neuropharmacology"},{"key":"R27-20230910","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbr.2010.11.055","article-title":"The role of NMDA and AMPA\/Kainate receptors in the consolidation of catalepsy sensitization","volume":"218","author":"Riedinger","year":"2011","journal-title":"Behav Brain Res"},{"key":"R28-20230910","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1527-3458.1997.tb00314.x","article-title":"Unique pharmacological profile of a novel antipsychotic drug, aripiprazole (OPC-14597)","volume":"3","author":"Sasa","year":"1997","journal-title":"CNS Drug Rev"},{"key":"R29-20230910","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbr.2015.06.041","article-title":"Brain regions associated with inverse incentive learning: c-Fos immunohistochemistry after haloperidol sensitization on the bar test in rats","volume":"293","author":"Schimmel","year":"2015","journal-title":"Behav Brain Res"},{"key":"R30-20230910","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF03033244","article-title":"Behavioural sensitization in addiction, schizophrenia, Parkinson\u2019s disease and dyskinesia","volume":"10","author":"Schmidt","year":"2006","journal-title":"Neurotox Res"},{"key":"R31-20230910","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1046\/j.1460-9568.1999.00794.x","article-title":"State-dependent blockade of haloperidol-induced sensitization of catalepsy by MK-801","volume":"11","author":"Schmidt","year":"1999","journal-title":"Eur J Neurosci"},{"key":"R33-20230910","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","article-title":"Atypical antipsychotics: mechanism of action","volume":"47","author":"Seeman","year":"2002","journal-title":"Can J Psychiatry"},{"key":"R34-20230910","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/syn.10297","article-title":"Intensification of cataleptic response in 6-hydroxydopamine-induced neurodegeneration of substantia nigra is not dependent on the degree of dopamine depletion","volume":"51","author":"Srinivasan","year":"2004","journal-title":"Synapse"},{"key":"R35-20230910","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0165-6147(98)01255-3","article-title":"Does the noncompetitive NMDA receptor antagonist dizocilpine (MK801) really block behavioural sensitization associated with repeated drug administration?","volume":"19","author":"Tzschentke","year":"1998","journal-title":"Trends Pharmacol Sci"},{"key":"R36-20230910","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00213-008-1457-4","article-title":"A neurocomputational account of catalepsy sensitization induced by D2 receptor blockade in rats: context dependency, extinction, and renewal","volume":"204","author":"Wiecki","year":"2009","journal-title":"Psychopharmacology"},{"key":"R37-20230910","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/026988119801200308","article-title":"Nicotine potentiates sulpiride-induced catalepsy in mice","volume":"12","author":"Zarrindast","year":"1998","journal-title":"J Psychopharmacol"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008877-201702000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T08:02:53Z","timestamp":1694332973000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008877-201702000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000264","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}